News

  • 16 October 2011

    NIH funds UCSF to develop antimalarial drugs

    The National Institutes of Health (NIH) has granted $718,136 in funding to the University of California San Francisco (UCSF) to discover and optimise oxaboroles as antimalarial drugs in collaboration with...

  • 11 October 2011

    Paladin Labs acquires Labopharm

    Canadian speciality pharmaceutical company Paladin Labs has completed the acquisition of all outstanding common shares of Labopharm.